Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
2.54M
-
Shares change
-
+90.1K
-
Total reported value, excl. options
-
$241M
-
Value change
-
+$8.53M
-
Number of buys
-
46
-
Number of sells
-
-23
-
Price
-
$94.77
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q1 2023
88 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q1 2023.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.54M shares
of 3.2M outstanding shares and own 79.36% of the company stock.
Largest 10 shareholders include FMR LLC (382K shares), T. Rowe Price Investment Management, Inc. (350K shares), RENAISSANCE TECHNOLOGIES LLC (207K shares), BlackRock Inc. (199K shares), VANGUARD GROUP INC (169K shares), DIMENSIONAL FUND ADVISORS LP (155K shares), RICE HALL JAMES & ASSOCIATES, LLC (114K shares), JPMORGAN CHASE & CO (85.5K shares), Ranger Investment Management, L.P. (72.5K shares), and STATE STREET CORP (71.4K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.